Loading...
Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...
Na minha lista:
| Udgivet i: | Case Rep Nephrol Dial |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5903093/ https://ncbi.nlm.nih.gov/pubmed/29692992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487921 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|